dlvr.it
Re: Muste et al.: Outcomes and complications of pars plana vitrectomy for nonclearing vitreous hemorrhage without tractional elements (Ophthalmology Retina. 2026;10:596–605)
In a large, 306-eye, retrospective study of patients undergoing pars plana vitrectomy for nonclearing vitreous hemorrhage with no tractional component, Muste et al1 found that preoperative anti-VEGF use improved visual outcome but did not lead to fewer recurrent vitreous hemorrhages or fewer repeat vitrectomies. This is a useful clinically based data set, and the authors honestly acknowledge some of the limitations of it.